Healthy Planet Hepatitis B
NCT04503993 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5004
Last updated 2022-05-10
Summary
This quality improvement project utilizes Epic Health Planet to increase screening for chronic hepatitis B through the creation of registries and ordering of hepatitis B laboratory panels.
Conditions
Interventions
- OTHER
-
Hepatitis B surface antigen, Hepatitis B core antibody, and Hepatitis B surface antibody
The hepatitis B tests are released into the electronic medical charts of at-risk patients who have never been screened for chronic hepatitis B using population health tools.
Sponsors & Collaborators
-
University of California, Davis
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-25
- Primary Completion
- 2021-07-24
- Completion
- 2021-12-31
Countries
- United States
Study Locations
More Related Trials
-
Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B
NCT02496897 ·Status: COMPLETED ·Phase: PHASE1
-
Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
NCT07328711 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
NCT06829329 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
NCT01298037 ·Status: ACTIVE_NOT_RECRUITING
-
An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B
NCT06745973 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
DEcentralize Testing, Education, and Linkage to Care by Using Electronic Best Practice Advisory for Hepatitis B (DETECT-B)
NCT06403657 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
NCT06779864 ·Status: RECRUITING
-
Research on Clinical Recovery and Maintenance Strategies for CHB
NCT06803368 ·Status: RECRUITING ·Phase: NA
-
"HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission"
NCT07054359 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients
NCT02327702 ·Status: UNKNOWN ·Phase: PHASE4
-
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
NCT07169656 ·Status: RECRUITING
-
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
NCT07307586 ·Status: RECRUITING ·Phase: PHASE3
-
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531
NCT02956850 ·Status: COMPLETED ·Phase: PHASE1
-
APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B
NCT03585322 ·Status: COMPLETED ·Phase: PHASE1
-
Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients
NCT03013556 ·Status: UNKNOWN ·Phase: PHASE4
-
Lamivudine for Chronic Hepatitis B
NCT00001457 ·Status: COMPLETED ·Phase: PHASE2
-
PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)
NCT00371761 ·Status: COMPLETED ·Phase: PHASE3
-
Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection
NCT03312023 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Virus Infection
NCT05542979 ·Status: COMPLETED ·Phase: PHASE1
-
HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy
NCT03350074 ·Status: COMPLETED
-
Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
NCT06668727 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B
NCT00753467 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment
NCT02365402 ·Status: UNKNOWN ·Phase: PHASE4
-
Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B
NCT02726789 ·Status: COMPLETED ·Phase: PHASE2
-
A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
NCT05727267 ·Status: RECRUITING ·Phase: PHASE1